Drug Discovery App CS WP

31. Build An AAV8 Platform: Lessons From A Collaborative Development Journey 11/5/2025

    Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.

32. Improving Productivity And Purity In ADC Polishing 11/5/2025

    Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.

33. An Innovative Solution For Continuous Low pH Flow-Through Virus Inactivation 11/5/2025

    Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.

34. Excellence In Peptide And Oligonucleotide Purification 11/5/2025

    Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.

35. Simple Orchestration Of Multiple Unit Operations 11/5/2025

    Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.

36. An Efficient End-To-End AAV8 Platform Process 11/5/2025

    Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.

37. Tools For Efficient And Reliable Gene Therapy Manufacturing 11/5/2025

    Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.

38. Enabling The Future Of Intensified Biomanufacturing 11/5/2025

    Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.

39. A Risk-Based Approach To Plasmid DNA And mRNA Process Development 9/23/2025

    Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.

40. Characterize Your PROTAC Hook Effect With Flexible In-Solution Affinity Measurements 9/3/2025

    Characterizing the PROTAC hook effect is crucial for selecting candidates with enhanced cooperativity. Gain confidence with flexible, in-solution affinity measurements that reveal key biophysical parameters and align with established three-component binding models.